NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 28 04:00PM ET
3.18
Dollar change
-0.04
Percentage change
-1.09
%
Index- P/E- EPS (ttm)-4.55 Insider Own0.56% Shs Outstand3.72M Perf Week9.83%
Market Cap11.85M Forward P/E- EPS next Y-0.28 Insider Trans0.00% Shs Float3.70M Perf Month-0.16%
Income-9.22M PEG- EPS next Q-0.95 Inst Own1.33% Short Float5.87% Perf Quarter-24.17%
Sales28.94M P/S0.41 EPS this Y62.78% Inst Trans67.12% Short Ratio3.22 Perf Half Y-81.21%
Book/sh6.04 P/B0.53 EPS next Y87.24% ROA-17.93% Short Interest0.22M Perf Year-87.01%
Cash/sh5.26 P/C0.61 EPS next 5Y68.36% ROE-69.11% 52W Range2.30 - 35.60 Perf YTD-62.79%
Dividend Est.- P/FCF- EPS past 5Y46.38% ROI-39.24% 52W High-91.05% Beta1.15
Dividend TTM- Quick Ratio1.56 Sales past 5Y100.58% Gross Margin65.33% 52W Low38.47% ATR (14)0.23
Dividend Ex-Date- Current Ratio1.76 EPS Y/Y TTM88.01% Oper. Margin-67.03% RSI (14)55.66 Volatility6.10% 8.33%
Employees28 Debt/Eq1.12 Sales Y/Y TTM502.92% Profit Margin-31.86% Recom2.00 Target Price33.00
Option/ShortYes / Yes LT Debt/Eq0.75 EPS Q/Q80.44% Payout- Rel Volume0.17 Prev Close3.22
Sales Surprise52.18% EPS Surprise-57.31% Sales Q/Q144.77% EarningsMar 31 BMO Avg Volume67.54K Price3.18
SMA2011.91% SMA500.88% SMA200-77.57% Trades Volume11,302 Change-1.09%
Date Action Analyst Rating Change Price Target Change
May-18-17Upgrade Maxim Group Hold → Buy $1 → $3
Feb-13-17Initiated Rodman & Renshaw Buy $3
Aug-12-16Downgrade Maxim Group Buy → Hold $4 → $1
Aug-17-15Reiterated Maxim Group Buy $8 → $4
Jul-27-15Reiterated ROTH Capital Buy $10.50 → $7
Jun-22-15Initiated JMP Securities Mkt Outperform $5
Apr-02-25 05:00PM
Mar-31-25 10:52AM
07:00AM
Mar-24-25 07:00AM
Jan-21-25 07:00AM
07:00AM Loading…
Jan-17-25 07:00AM
Jan-06-25 08:57AM
Dec-10-24 08:30AM
Nov-26-24 10:00AM
Nov-25-24 07:00AM
Nov-22-24 06:35AM
Nov-21-24 06:30AM
Nov-20-24 07:19AM
Nov-05-24 09:00AM
Oct-16-24 07:00AM
01:01PM Loading…
Sep-17-24 01:01PM
Aug-15-24 07:00AM
Aug-08-24 07:00AM
Jun-18-24 07:37AM
Jun-05-24 03:17PM
May-30-24 07:00AM
May-29-24 08:03AM
May-28-24 11:53AM
07:00AM
May-24-24 07:00AM
May-22-24 07:00AM
May-17-24 05:00PM
May-06-24 07:00AM
Apr-17-24 07:00AM
Apr-10-24 07:00AM
09:00AM Loading…
Apr-01-24 09:00AM
Mar-27-24 12:23PM
Mar-26-24 07:00AM
Mar-20-24 07:00AM
Mar-06-24 08:00AM
Mar-04-24 07:00AM
Feb-28-24 07:00AM
Feb-25-24 02:12PM
Feb-16-24 07:00AM
Dec-21-23 07:00AM
Nov-21-23 03:45PM
Nov-20-23 07:00AM
Nov-13-23 07:00AM
Nov-02-23 03:12PM
Oct-31-23 09:00AM
Oct-30-23 11:38AM
Oct-12-23 07:00AM
Sep-28-23 07:00AM
Sep-19-23 07:00AM
Sep-14-23 05:36AM
Sep-11-23 07:00AM
Sep-05-23 06:04AM
Aug-31-23 08:18AM
Aug-30-23 07:00AM
Aug-22-23 07:00AM
Aug-07-23 02:34PM
Jul-18-23 03:22PM
Jul-17-23 07:00AM
Jun-29-23 02:00PM
Jun-07-23 05:25AM
May-24-23 07:00AM
May-17-23 07:00AM
May-04-23 01:56PM
Apr-25-23 07:00AM
Apr-17-23 11:00AM
Apr-04-23 08:21PM
Mar-24-23 07:15AM
Mar-23-23 11:42AM
Mar-22-23 07:00AM
Mar-15-23 07:00AM
Mar-06-23 07:00AM
Jan-04-23 07:00AM
Dec-20-22 12:36PM
07:00AM
Dec-05-22 04:00AM
Nov-28-22 04:30PM
Nov-15-22 07:00AM
Nov-10-22 04:30PM
07:00AM
Nov-04-22 04:30PM
Nov-03-22 09:11AM
Nov-02-22 09:21AM
Sep-27-22 07:00AM
Sep-19-22 08:00AM
Sep-15-22 12:38PM
07:00AM
Sep-12-22 07:00AM
Aug-18-22 07:47AM
Aug-16-22 07:00AM
Aug-11-22 07:00AM
Jun-29-22 08:00AM
Jun-28-22 07:00AM
Jun-16-22 07:00AM
May-12-22 10:16AM
May-11-22 07:00AM
May-05-22 07:00AM
Mar-17-22 08:55AM
Mar-16-22 07:00AM
Mar-10-22 07:00AM
Mar-03-22 07:00AM
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.